Evaluating a centralised cancer support centre in the remote region of Northern Norway

by Bente Ervik, Sigve Andersen, Helge Skirbekk, Tom Donnem
Published 2020-09-01

Transcriptomic signals in blood prior to lung cancer focusing on time to diagnosis and metastasis

by Therese H. Nøst, Marit Holden, Tom Dønnem, Hege Bøvelstad, Charlotta Rylander, Eiliv Lund, Torkjel M. Sandanger
Published 2021-04-01

Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.

by Thomas K Kilvaer, Andrej Valkov, Sveinung Sorbye, Eivind Smeland, Roy M Bremnes, Lill-Tove Busund, Tom Donnem
Published 2010-01-01

Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.

by Sigve Andersen, Tom Donnem, Khalid Al-Shibli, Samer Al-Saad, Helge Stenvold, Lill-Tove Busund, Roy M Bremnes
Published 2011-01-01

Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.

by Sigve Andersen, Tom Donnem, Helge Stenvold, Samer Al-Saad, Khalid Al-Shibli, Lill-Tove Busund, Roy M Bremnes
Published 2011-01-01

The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas.

by Andrej Valkov, Sveinung W Sorbye, Thomas K Kilvaer, Tom Donnem, Eivind Smeland, Roy M Bremnes, Lill-Tove Busund
Published 2011-01-01

Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival

by Thomas Karsten Kilvaer, Andrej Valkov, Sveinung W. Sorbye, Tom Donnem, Eivind Smeland, Roy Martin Bremnes, Lill-Tove Busund
Published 2010-01-01

Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.

by Thomas K Kilvaer, Erna-Elise Paulsen, Sigurd M Hald, Tom Wilsgaard, Roy M Bremnes, Lill-Tove Busund, Tom Donnem
Published 2015-01-01

Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma

by Eivind Smeland, Thomas K. Kilvaer, Sveinung Sorbye, Andrej Valkov, Sigve Andersen, Roy M. Bremnes, Lill-Tove Busund, Tom Donnem
Published 2012-01-01

Prognostic impact of lymphocytes in soft tissue sarcomas.

by Sveinung W Sorbye, Thomas Kilvaer, Andrej Valkov, Tom Donnem, Eivind Smeland, Khalid Al-Shibli, Roy M Bremnes, Lill-Tove Busund
Published 2011-01-01

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.

by Samer Al-Saad, Elin Richardsen, Thomas K Kilvaer, Tom Donnem, Sigve Andersen, Mehrdad Khanehkenari, Roy M Bremnes, Lill-Tove Busund
Published 2017-01-01

Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.

by Sveinung W Sorbye, Thomas K Kilvaer, Andrej Valkov, Tom Donnem, Eivind Smeland, Khalid Al-Shibli, Roy M Bremnes, Lill-Tove Busund
Published 2012-01-01

Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.

by Thomas Karsten Kilvaer, Mehrdad Rakaee, Turid Hellevik, Arne Østman, Carina Strell, Roy M Bremnes, Lill-Tove Busund, Tom Dønnem, Inigo Martinez-Zubiaurre
Published 2018-01-01

Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC

by Thomas Karsten Kilvaer, Mehrdad Rakaee, Turid Hellevik, Jørg Vik, Luigi De Petris, Tom Donnem, Carina Strell, Arne Ostman, Lill-Tove Rasmussen Busund, Inigo Martinez-Zubiaurre
Published 2019-07-01

High progesterone receptor expression in prostate cancer is associated with clinical failure.

by Thea Grindstad, Sigve Andersen, Samer Al-Saad, Tom Donnem, Yury Kiselev, Christian Nordahl Melbø-Jørgensen, Kaja Skjefstad, Lill-Tove Busund, Roy M Bremnes, Elin Richardsen
Published 2015-01-01

Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.

by Thomas K Kilvaer, Mehrdad Rakaee Khanehkenari, Turid Hellevik, Samer Al-Saad, Erna-Elise Paulsen, Roy M Bremnes, Lill-Tove Busund, Tom Donnem, Inigo Z Martinez
Published 2015-01-01

Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival.

by Marte Eilertsen, Sigve Andersen, Samer Al-Saad, Yury Kiselev, Tom Donnem, Helge Stenvold, Ingvild Pettersen, Khalid Al-Shibli, Elin Richardsen, Lill-Tove Busund, Roy M Bremnes
Published 2014-01-01

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry

by Mehrdad Rakaee, Lill-Tove Rasmussen Busund, Simin Jamaly, Erna-Elise Paulsen, Elin Richardsen, Sigve Andersen, Samer Al-Saad, Roy M. Bremnes, Tom Donnem, Thomas K. Kilvaer
Published 2019-03-01

MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer.

by Tom Donnem, Christopher G Fenton, Kenneth Lonvik, Thomas Berg, Katrine Eklo, Sigve Andersen, Helge Stenvold, Khalid Al-Shibli, Samer Al-Saad, Roy M Bremnes, Lill-Tove Busund
Published 2012-01-01

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort.

by Elin Richardsen, Sigve Andersen, Samer Al-Saad, Mehrdad Rakaee, Yngve Nordby, Mona Irene Pedersen, Nora Ness, Thea Grindstad, Ingeborg Movik, Tom Dønnem, Roy Bremnes, Lill-Tove Busund
Published 2017-01-01